Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.
PLoS Negl Trop Dis. 2023 Aug 15;17(8):e0011545. doi: 10.1371/journal.pntd.0011545. eCollection 2023 Aug.
Envenomations by African snakes represent a high burden in the sub-Sahara region. The design and fabrication of polyspecific antivenoms with a broader effectiveness, specially tailored for its use in sub-Saharan Africa, require a better understanding of the immunological features of different Naja spp. venoms of highest medical impact in Africa; and to select the most appropriate antigen combinations to generate antivenoms of wider neutralizing scope.
METHODOLOGY/PRINCIPAL FINDINGS: Rabbit-derived monospecific antisera were raised against the venoms of five spitting cobras and six non-spitting cobras. The effects of immunization in the animal model were assessed, as well as the development of antibody titers, as proved by immunochemical assays and neutralization of lethal, phospholipase A2 and dermonecrotic activities. By the end of the immunization schedule, the immunized rabbits showed normal values of all hematological parameters, and no muscle tissue damage was evidenced, although alterations in aspartate aminotransferase (AST) and alkaline phosphatase (ALP) suggested a degree of hepatic damage caused mainly by spitting cobra venoms. Immunologic analyses revealed a considerable extent of cross-reactivity of monospecific antisera against heterologous venoms within the spitting and no-spitting cobras, yet some antisera showed more extensive cross-reactivity than others. The antisera with the widest coverage were those of anti-Naja ashei and anti-N. nigricollis for the spitting cobras, and anti-N. haje and anti-N. senegalensis for the non-spitting cobras.
CONCLUSIONS/SIGNIFICANCE: The methods and study design followed provide a rationale for the selection of the best combination of venoms for generating antivenoms of high cross-reactivity against cobra venoms in sub-Saharan Africa. Results suggest that venoms from N. ashei, N. nigricollis within the spitting cobras, and N. haje and N. senegalensis within the non-spitting cobras, generate antisera with a broader cross-reactivity. These experimental results should be translated to larger animal models used in antivenom elaboration to assess whether these predictions are reproduced.
非洲蛇类的咬伤在撒哈拉以南地区造成了很大的负担。为了设计和制造更广泛有效的多价抗蛇毒血清,专门针对撒哈拉以南非洲地区使用,需要更好地了解不同的 Naja spp. 毒液的免疫特性。这些毒液在非洲具有最高的医学影响,需要选择最合适的抗原组合来产生更广泛中和范围的抗蛇毒血清。
方法/主要发现:用 5 种喷毒眼镜蛇和 6 种不喷毒眼镜蛇的毒液制备兔源性单特异性抗血清。评估了动物模型中的免疫效果,以及免疫化学测定和致死、磷脂酶 A2 和皮肤坏死活性中和证实的抗体滴度的发展。在免疫计划结束时,免疫兔显示所有血液学参数的正常值,并且没有肌肉组织损伤的证据,尽管天冬氨酸氨基转移酶(AST)和碱性磷酸酶(ALP)的改变表明主要由喷毒眼镜蛇毒液引起的一定程度的肝损伤。免疫分析显示单特异性抗血清对喷毒和不喷毒眼镜蛇中异源毒液具有相当大的交叉反应性,但一些抗血清的交叉反应性比其他抗血清更广泛。覆盖范围最广的抗血清是针对喷毒眼镜蛇的抗 Naja ashei 和抗 N. nigricollis,以及针对不喷毒眼镜蛇的抗 N. haje 和抗 N. senegalensis。
结论/意义:所遵循的方法和研究设计为选择最佳的毒液组合提供了依据,以产生针对撒哈拉以南非洲眼镜蛇毒液的高交叉反应性抗蛇毒血清。结果表明,来自喷毒眼镜蛇中的 N. ashei、N. nigricollis 和非喷毒眼镜蛇中的 N. haje 和 N. senegalensis 的毒液产生了更广泛的交叉反应性抗血清。这些实验结果应该转化为更大的动物模型中用于评估这些预测是否重现。